SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-007826
Filing Date
2022-05-09
Accepted
2022-05-09 16:15:14
Documents
14
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mxct-20220509x8k.htm   iXBRL 8-K 39121
2 EX-99.1 mxct-20220509xex99d1.htm EX-99.1 280760
3 GRAPHIC mxct-20220509xex99d1001.jpg GRAPHIC 7633
  Complete submission text file 0001558370-22-007826.txt   474008

Data Files

Seq Description Document Type Size
4 EX-101.SCH mxct-20220509.xsd EX-101.SCH 3052
5 EX-101.LAB mxct-20220509_lab.xml EX-101.LAB 16682
6 EX-101.PRE mxct-20220509_pre.xml EX-101.PRE 10821
8 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20220509x8k_htm.xml XML 4972
Mailing Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

IRS No.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 22905129
SIC: 8731 Services-Commercial Physical & Biological Research